Beruflich Dokumente
Kultur Dokumente
ABSTRACT
cytogenetic studies to date have shown essentially all angiolipomas to have normal karyotype.2,3
ascular lesions represent a minority of tumors originating in the breast. The most common entities are benign and include hemangiomas and angiolipomas. Malignant vascular lesions (angiosarcomas) are rare and may be primary or secondary to radiation. Also appreciated in association to radiotherapy is the development of cutaneous atypical vascular lesion affecting the skin of the breast. The relationship of the latter to radiation-associated angiosarcoma is controversial and remains to be elucidated. This article reviews the most likely encountered vascular lesions in the breast, with emphasis on key pathologic diagnostic features and potential diagnostic pitfalls.
GROSS FEATURES
Angiolipoma is usually small (<2 cm) and well circumscribed and often encapsulated. The cut surface typically is yellow and somewhat lobulated, indistinguishable from a conventional lipoma. As the vascular component increases in angiolipomas, tumors may appear more firm and/or red in color.
MICROSCOPIC FEATURES
Angiolipoma is well demarcated from the surrounding breast parenchyma and is characterized by a proliferation of mature adipocytic tissue admixed with varying amounts of small-caliber capillary vessels showing prominent intravascular fibrin microthrombi (Fig. 1A, B). The adipocytic component is benign appearing with no atypia, hyperchromasia, or pleomorphism. The small vessels tend to
ANGIOLIPOMA OVERVIEW
Angiolipoma is a common, benign tumor that affects primarily young and middle-aged adults and arises primarily within the subcutaneous tissue of the limbs. Lesions may be solitary or multiple. When in the breast, angiolipoma may affect subcutis and mammary parenchyma. Similar to angiolipomas elsewhere on the body, patients with subcutaneous lesions arising on the skin of the breast present with a painful wellcircumscribed nodule. When arising within the parenchyma of the breast, this neoplasm shows a wide age distribution and presents as a small and painless nodule.1 Although angiolipoma has been considered to represent a variant of lipomas,
a Department of Pathology, Brigham and Womens Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA b Department of Pathology, Baptist Hospital of Miami, 8900 N Kendall Drive, Miami, FL 33176, USA * Corresponding author. E-mail address: AlessandraFN@bapisthealth.net
Surgical Pathology 5 (2012) 645659 http://dx.doi.org/10.1016/j.path.2012.06.002 1875-9181/12/$ see front matter 2012 Published by Elsevier Inc.
surgpath.theclinics.com
646
647
OF
Pitfall ANGIOLIPOMA
! Fibrin microthrombi must be present in the absence of changes suggestive of trauma to the lesion.
be thick walled and more densely located at the periphery of the lesion. In cellular examples of angiolipoma, the vascular component predominates with little to no admixed adipose tissue (see Fig. 1C). Mitotic activity is typically low, although in cellular angiolipomas there may be focal high mitotic activity. Cytologic atypia is absent.
DIFFERENTIAL DIAGNOSIS
Although angiolipoma is usually a straightforward diagnosis, in some instances, such as small core biopsies, the correct diagnosis may be difficult. Adipocytic-predominant angiolipoma should be distinguished from lipoma and atypical lipomatous tumor (ALT). Although lipomas are also well circumscribed, often with a delicate fibrous capsule, they have limited vascularity. Fibrin microthrombus is not a feature of lipomas. ALT shows variation in adipocyte size and shape, cellular fibrous septae containing hyperchromatic atypical cells, and, occasionally, lipoblasts. Immunostains for MDM2 and CDK4 show nuclear staining in more than 95% of ALTs.4 Cellular angiolipomas have only a minimal adipocytic component and, therefore, may be mistaken for a hemangioma or angiosarcoma. In contrast to angiolipoma, hemangioma shows vessels of various calibers and absence of fibrin microthrombi. Angiosarcoma shows angulated vascular channels with dissecting architecture, nuclear atypia, and pleomorphism (discussed later). Immunohistochemistry in angiolipoma and angiosarcoma shows vessels to be positive for markers, such as CD31 and CD34; however, in contrast to angiolipoma, angiosarcoma lacks smooth muscle actinpositive pericytes surrounding vascular channels.
PROGNOSIS
Angiolipoma is benign and simple excision is curative. There is no potential for local recurrence or metastasis.
Often, but not always, associated with lobules and/or ducts No nuclear atypia, hyperchromasia, or multilayering
648
DIFFERENTIAL DIAGNOSIS
The diagnosis of perilobular hemangioma is often straightforward and requires no additional immunostains. Pseudoangiomatous stromal hyperplasia (PASH) may morphologically overlap with perilobular hemangioma; however, in contrast to hemangiomas, the cells lining the spaces in PASH are fibroblasts and myofibroblasts and do not express vascular markers, such as CD31, nor are the spaces filled with blood. Other types of hemangiomas of the breast are often larger (>2 cm) and not closely associated with the lobular unit. In a few specimens, the possibility of angiosarcoma may be raised; however, in contrast to perilobular hemangioma, vessels composing angiosarcoma show a prominent dissecting growth pattern around breast parenchyma and in adipose tissue, and endothelial cells display nuclear atypia, multilayering and hyperchromasia (discussed later).
OF
! The lesion is unencapsulated and shows anastomosing small vessels. ! Vascular channels may show a dissecting growth pattern but it is limited.
PROGNOSIS
Perilobular hemangioma is a benign condition that requires no treatment.
HEMANGIOMA OVERVIEW
Hemangiomas of the breast are a benign group of lesions with a broad morphologic spectrum and are potentially diagnostically challenging in small core biopsies. Overall, they affect patients in a wide age range and may arise within breast parenchyma or subcutaneous tissue of the breast. For the purpose of this article, only hemangiomas arising within the breast parenchyma are discussed.
649
GROSS FEATURES
Macroscopically, hemangioma is a lobulated, wellcircumscribed lesion, albeit unencapsulated, located within the breast parenchyma and measuring up 5 cm.7 The cut surface is soft, dark red, or brown and hemorrhagic.
Cytologically, the neoplastic cells lining hemangioma vessels are flat and show some degree of hyperchromasia; however, there is no appreciable nuclear atypia or multilayering (see Fig. 3C).
MICROSCOPIC FEATURES
Histologically, hemangioma of the breast can often be subclassified into 3 main categories, namely, cavernous, capillary, or complex (or mixed). Cavernous hemangioma (Fig. 3A) is characterized by proliferation of large dilated vessels separated by fibrous septae. Occasionally, areas of thrombosis, infarction, and revascularization may be present. Within these areas, increased numbers of mitoses may be present as well as calcifications and micropapillary structures, consistent with recanalization. When thrombosis and recanalization are extensive, it is often difficult to appreciate the presence of a pre-existing hemangioma, and these lesions are often referred to as intravascular papillary endothelial hyperplasia or Masson tumor.8 Capillary hemangioma is composed of small vessels with muscular walls (see Fig. 3B). A larger feeding vessel is often identified at the periphery of the lesion. In complex hemangioma, there is a mixture of large, thin-walled, dilated vessels and small capillary-sized vessels.
DIFFERENTIAL DIAGNOSIS
The differential diagnosis of hemangiomas is primary mammary angiosarcoma of low and intermediate histologic grade, particularly in small core biopsies. In contrast to hemangioma, angiosarcoma usually demonstrates a dissecting growth pattern as well as cytologic atypia. In small samples, however, it may be difficult to appreciate the edge of the neoplasm and excision of the lesion may be necessary for further evaluation of the lesion. In areas of Masson tumor, there may be increased cellularity and mitotic activity, similar to what is seen in intermediate-grade angiosarcoma; however, frank nuclear atypia is not present. Although immunoperoxidase studies are not helpful in this differential, it has been suggested that Ki-67 index in these 2 lesions may be useful.9 In one study, hemangiomas showed positivity for MIB-1 in 1.7% of neoplastic nuclei, whereas in angiosarcomas, 40.3% of the nuclei are positive.9 The applicability of this stain in core biopsy specimens, however, remains to be validated.
PROGNOSIS
OF
Pitfall HEMANGIOMA
! Areas of thrombosis and revascularization may contain increased mitotic activity and formation of intralesional papillary structures (Masson tumor).
650
651
DIFFERENTIAL DIAGNOSIS
In the appropriate clinical context, the differential diagnosis for AVL is cutaneous hemangioma and radiation-associated low-grade cutaneous angiosarcoma. Cutaneous hemangioma is usually well circumscribed and shows no evidence of dissection of dermal collagen as well as absent nuclear atypia. In contrast to AVL, cutaneous angiosarcoma shows a less-circumscribed tumor area with infiltration into deep dermis and subcutaneous tissue and dissecting growth patterns. In addition, low-grade angiosarcoma is characterized by nuclear atypia, hyperchromasia, and multilayering. The distinction between these 2 entities is based on histologic finding; however, recently, molecular studies have shown that amplification of MYC and FLT4 genes is present in radiation-associated angiosarcoma (RAS) and not seen in AVLs.15
GROSS FEATURES
AVLs present clinically as small, erythematous, painless papules or nodules on the irradiated skin, almost always less than 1 cm in greatest dimension.
MICROSCOPIC FEATURES
Histologically, AVLs are characterized by a proliferation of thin-walled, dilated, anastomosing vascular channels. The lesion tends to be well circumscribed within the dermis and is often wedgeshaped (Fig. 4A). Extension into subcutaneous fat or breast parenchyma is not a feature of this lesion. Cytologically, the vessels are lined by a single layer of hyperchromatic endothelial cells with or without hobnailing (see Fig. 4B). There is no nuclear pleomorphism or atypia and no endothelial multilayering. Focally, the formation of small papillary tufts of endothelial cells extending into the vessel lumen, however, may be seen.
PROGNOSIS
The clinical course of AVLs is benign in the majority of cases. Although AVLs may recur and patients may develop new lesions, progression to angiosarcoma is rare, occurring in less than 1% of reported cases.4 Surgical excision is the main therapy; however, patients require long-term follow-up to monitor future recurrences.
OF
OF
Wedge-shaped lesion limited to the dermis Thin-walled anastomosing vessels Hyperchromatic cells with or without hobnailing but no atypia Small intraluminal papillary formations
! Extension of the lesion into subcutaneous tissue warrants the diagnosis of low-grade angiosarcoma. ! Although there seems to be minimal relationship between AVLs and angiosarcoma, close follow-up should be recommended.
652
in patients treated conservatively for breast carcinoma. The estimated incidence RAS is approximately 0.16%.16 Patients are typically postmenopausal and are distinctly older than the population affected by primary mammary angiosarcoma (average age at diagnosis for RAS is 70 years).1619 The interval between exposure to
653
MICROSCOPIC FEATURES
RAS is a mostly dermal-based lesion frequently showing involvement of underlying subcutaneous tissue and, less likely, underlying breast parenchyma. Similarly to soft tissue angiosarcomas, RAS can morphologically be classified into 3 histologic grades: 1. Grade I (low grade) 2. Grade II (intermediate grade) 3. Grade III (high grade)
GROSS FEATURES
Grossly, RAS presents in previously irradiated skin and may have a varied appearance in regard to size and color. Usually angiosarcomas are larger than 1 cm and not uncommonly may present as large or multifocal lesions. Skin often shows a reddish discoloration or ecchymosis-like pattern.
Fig. 5. (A) RAS shows a prominent dissecting pattern within the dermis and subcutaneous tissue. Nuclear atypia is a common finding in RAS (B) as well as multilayering of neoplastic cells (C).
654
OF
Low-grade RAS
655
! Expression of vascular markers by immunoperoxidase stains is variable in angiosarcoma and a comprehensive panel may be applied to these lesions, including CD31, CD34, D2-40, cytokeratins (AE1/AE3, Pan-K, CAM 5.2), S100, and other melanocytic markers.
epithelioid RAS. Poorly differentiated carcinoma of cutaneous origin as well as malignant melanoma may show evidence of an in situ or junctional component, aiding in the differential. Immunoperoxidase stains can be useful in the differential diagnosis. Although RAS is positive for vascular markers, poorly differentiated carcinoma is at least focally positive for cytokeratins, and melanoma is positive for S-100 protein and other melanocytic markers.
PROGNOSIS
The mainstay of treatment of RAS is surgical resection with wide margins. The utility of chemotherapy and radiation remains uncertain in this entity. RAS is a locally aggressive neoplasm regardless of tumor grade, with a tendency for local recurrence and, less often, distant metastasis. The rate of local recurrence is reportedly between 40% and 80%.1619 The median survival for patients with RAS is 33.5 to 37.4 months.17,18
DIFFERENTIAL DIAGNOSIS
The differential diagnosis of low-grade and intermediate-grade RAS includes cutaneous hemangioma and AVL, whereas high-grade and epithelioid RAS must be differentiated from poorly differentiated carcinoma and malignant melanoma. Cutaneous hemangioma is a superficial, well-circumscribed vascular proliferation lacking nuclear atypia or dissecting growth pattern. AVL, as described previously, is limited to the upper dermis. Although hyperchromasia may be present, there is no nuclear atypia or endothelial multilayering. Poorly differentiated carcinoma and malignant melanoma show a solid growth pattern and may involve dermis and subcutaneous tissue of the breast, histologically resembling high-grade and
GROSS FEATURES
Grossly, primary angiosarcoma presents as an intramammary, red, hemorrhagic mass with fairly well defined borders. Focally, there might be extension into overlying skin.
656
OF
Low-grade Angiolipoma angiosarcoma Hemangioma High-grade Poorly differentiated angiosarcoma carcinoma Metastatic malignant melanoma NHL, large cell type Malignant phyllodes tumor with heterologous elements Dedifferentiated liposarcoma with heterologous differentiation
MICROSCOPIC FEATURES
Similarly to RAS of the breast and soft tissue angiosarcoma, primary mammary angiosarcoma can be histologically graded as in 3 categories, namely, low, intermediate, or high. Low-grade primary mammary angiosarcoma is characterized by a proliferation of thin-walled vascular channels with a prominent dissecting architecture throughout the breast parenchyma and adipose tissue (Fig. 6A). Focally, endothelial multilayering may be seen. Intermediate-grade angiosarcoma shows areas of increased cellularity and papillae formation of neoplastic cells (see Fig. 6). Frequent mitoses and focal necrosis may be present. High-grade angiosarcoma is characterized by the proliferation of neoplastic cells in solid sheets with focal formation of blood lakes (see Fig. 6). Additionally, angiosarcoma can demonstrate epithelioid morphology with tumor cells showing round nuclei and moderate amount of palely eosinophilic cytoplasm (see Fig. 6). Within a single tumor, there may be great variability in grading, with low-grade morphology often apparent at the periphery of the tumor mass.
DIFFERENTIAL DIAGNOSIS
The main differential diagnosis of low-grade mammary angiosarcoma is benign hemangioma and angiolipoma. In the latter 2 entities, there is no infiltration and dissection of surrounding breast parenchyma and adipose tissue. In addition, atypia is not seen in hemangioma and angiolipoma. In small biopsies, the distinction can be difficult and complete excision of the lesion may be recommended for definitive diagnosis. High-grade and/or epithelioid angiosarcoma may overlap morphologically with poorly differentiated
carcinoma, metastatic melanoma to the breast, and non-Hodgkin lymphoma (NHL), large cell type. In poorly differentiated carcinoma, neoplastic cells grow in sheet and there may be focal degenerating areas mimicking a vascular proliferation. Immunoperoxidase studies are of great utility for the differential. Poorly differentiated carcinoma is positive for at least one cytokeratin although negative for vascular markers. Metastatic malignant melanoma also shows sheets of neoplastic cells with round nuclei and prominent eosinophilic nucleoli. Vasoformative architecture is not a feature of melanoma. Immunostain for S-100 protein and other melanocytic markers may aid in the distinction. NHL, large cell type, is often a discohesive proliferation of large atypical cells lacking a vasoformative appearance. As part of the panel of stains, leukocyte common antigen as well as specific markers for T lymphocytes and B lymphocytes, such as CD20, BSAP, and CD3, among others, may be added for the diagnosis and subclassification of NHL. Finally, rarely, angiosarcoma may also be present as part of other malignant mesenchymal neoplasm involving the breast, such as malignant phyllodes tumor or dedifferentiated liposarcoma with heterologous differentiation. The presence of leaflet-like architecture as well as the existence of other heterologous elements, such as chondrosarcomatous or osteosarcomatous components, is helpful in the diagnosis of phyllodes tumor. Dedifferentiated liposarcoma involving breast parenchyma is a rare phenomenon and may demonstrate the presence of heterologous elements. In addition to identifying a well-differentiated adipocytic component to the tumor, MDM2 and CDK4 may aid in the recognition of dedifferentiated liposarcoma; however, these markers may also be expressed in other neoplasms.4 Appropriate sampling of the neoplasm is
657
Fig. 6. (A) Low-grade primary angiosarcoma of the breast is characterized by a florid dissecting architecture within mammary parenchyma. (B) Intermediate-grade angiosarcoma shows increased cellularity and formation of papillary structures within the lumen of the vascular channels.
pivotal for the correct diagnosis of either phyllodes tumor or dedifferentiated liposarcoma.
OF
PROGNOSIS
Surgery with wide uninvolved margins (ie, mastectomy) is the mainstay of treatment of primary mammary angiosarcoma. The prognosis is similar to angiosarcoma arising in other soft tissue sites, including RAS, and is independent
! Primary angiosarcoma may rarely be associated with history of prior radiation exposure. ! Definitive diagnosis and histologic grading of angiosarcoma may require complete excision of the lesion.
658
of histologic tumor grade.20,21 Approximately 25% of patients develop local recurrence and 60% have evidence of distance metastasis.20 The most common sites for the development of metastatic disease are lung, liver, skin, and bones.20
REFERENCES
1. Kryvenko ON, Chitale DA, VanEgmond EM, et al. Angiolipoma of the female breast: clinicopathological correlation of 52 cases. Int J Surg Pathol 2011;18: 3543.
659